Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes
Frontiers in Endocrinology · 15.05.2026 · 17
DOI: 10.3389/fendo.2026.1844237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 15.05.2026. Verfasst von Xi He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Heart Center of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Percutaneous Coronary Intervention, Cholesterol, HDL, Cardiovascular Diseases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel, reliable indicator of dyslipidemia. However, its association with cardiac outcomes in patients with type 2 diabetes mellitus (T2DM) following percutaneous coronary intervention (PCI) remains unclear. We investigated the association of the NHHR with the risks of major adverse cardiovascular events (MACEs) following PCI in adults with T2DM.
Methods
This retrospective cohort study included 1176 adults with T2DM undergoing PCI after new-onset acute myocardial infarction between January 1, 2019, and December 31, 2023. Patients were categorized into NHHR quartiles. The relationship between the NHHR and post-PCI MACE risk was investigated using univariate and multivariate Cox regression analyses. Restricted cubic splines and smooth curve fitting evaluated the nonlinear association between the NHHR and MACE risk; receiver operating characteristic (ROC) curves determined the prognostic significance of the NHHR.
Results
Over 21.0 ± 6.6 months, 246 MACEs occurred. In multivariate analysis, the NHHR was associated with MACE incidence, even after adjustments (vs. group Q1: hazard ratio [95% confidence interval] in groups Q3 and Q4, 4.00 [2.47–6.48] and 6.28 [3.92–10.05], respectively; both P < 0.05). The NHHR and MACEs were non-linearly related. Within the threshold of 3.12–5.10, every 1-unit rise in the NHHR elevated the MACE risk 1.4-fold. The area under the ROC curve of the NHHR combined with the Global Registry of Acute Coronary Events risk score was 0.84 for predicting post-PCI MACEs (sensitivity, 71.54%; specificity, 83.86%). The NHHR/MACE association persisted in subgroup analysis. No significant interactive effects were found for age, sex, hypertension, smoking, body mass index, glycated hemoglobin, and medications (P for interaction > 0.05).
Conclusions
Our findings suggested a nonlinear positive association between NHHR and MACE risk in T2DM patients undergoing PCI. Routine NHHR assessment may facilitate early risk identification and tailored care for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Heart Center of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
- NHC Key Laboratory of Etiological Epidemiology of Chronic Diseases with High Incidence in Fujian-Taiwan Area (Co-construction), Fujian Medical University, Fuzhou, China.
Zitieren
APA
He, X., He, G., Qi, L., Chen, Y., Lin, Z., Chen, W., Huang, Q., Liu, L., Chen, Z., & Gao, R. (2026). Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1844237
Vancouver
He X, He G, Qi L, Chen Y, Lin Z, Chen W, et al. Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1844237
BibTeX
@article{He2026,
author = {He, Xi and He, Guanlian and Qi, Liqin and Chen, Yujie and Lin, Zhaorong and Chen, Wenjia and Huang, Qintao and Liu, Libin and Chen, Zhaoyang and Gao, Ruonan},
title = {Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.1844237}
}
EUVIMED